Skip to main content
Premium Trial:

Request an Annual Quote

CytRx Subsidiary Araios Partners with 3rd Millennium on RNAi Informatics

NEW YORK, Nov. 21 (GenomeWeb News) - CytRx announced today that its subsidiary Araios, based in Worcester, Mass., will collaborate with 3rd Millennium to establish an informatics platform for RNAi-based drug development in the areas of type II diabetes and obesity.

 

CytRx scientists will use the system to generate target libraries for these two diseases. The company will also work with 3rd Millennium to build informatics infrastructure, virtual library construction, homology modeling, and virtual screening workflow for its small molecule discovery program.

 

Financial details of the collaboration were not disclosed.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.